Suspension of trading
Heritage Cannabis Holdings Corp. Stock
Stocks
2UE
CA42727B1094
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
02:12:05 2024-04-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.000500 EUR | -.--% |
|
-.--% | - |
| Market Cap | 749K 537K 481K 442K 401K 51M 763K 5.28M 2.12M 26.83M 2.02M 1.97M 84.6M | P/E 2022 |
-1.08x | P/E 2023 | -0.38x |
|---|---|---|---|---|---|
| Enterprise Value | 5.28M 3.79M 3.39M 3.12M 2.83M 359M 5.38M 37.19M 14.93M 189M 14.21M 13.9M 596M | EV / Sales 2022 |
1,322,235x | EV / Sales 2023 | 407,556x |
| Free-Float |
85.98% | Yield 2022 * |
-
| Yield 2023 | - |
| 3 years | 0 | 0.02 | |
| 5 years | 0 | 0.06 | |
| 10 years | 0 | 0.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2021-08-03 | |
Jasmine Paige
DFI | Director of Finance/CFO | - | 2023-08-13 |
Eoin Hegarty
COO | Chief Operating Officer | - | 2023-02-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2021-08-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/26/24 | Other | Director | 0 | 0% | ||
| 1/26/24 | Sell | Chief Financial Officer | 2,000,000 | 0.2147% | ||
| 1/26/24 | Sell | Chief Operating Officer | 2,666,666 | 0.2863% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -90.91% | 562K | ||
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | ||
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | ||
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | ||
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | ||
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | ||
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | ||
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | ||
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | ||
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | ||
| Average | +1.88% | +5.31% | +41.92% | +67.01% | 426.19B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.44% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 29.57 21.19 18.98 17.46 15.82 2.01K 30.12 208.17 83.57 1.06K 79.53 77.83 3.34K | 29.79 21.35 19.12 17.59 15.94 2.03K 30.35 209.78 84.21 1.07K 80.14 78.43 3.36K |
| Net income | -24.24M -17.38M -15.56M -14.31M -12.97M -1.65B -24.7M -171M -68.53M -868M -65.21M -63.82M -2.74B | -20.1M -14.4M -12.9M -11.86M -10.75M -1.37B -20.47M -141M -56.8M -719M -54.05M -52.9M -2.27B |
| Net Debt | 11.54M 8.27M 7.41M 6.82M 6.18M 785M 11.76M 81.27M 32.63M 413M 31.05M 30.39M 1.3B | 4.53M 3.25M 2.91M 2.68M 2.42M 308M 4.62M 31.91M 12.81M 162M 12.19M 11.93M 512M |
Employees
2
Sector
Pharmaceuticals
- Stock Market
- Stocks
- 2UE Stock
Select your edition
All financial news and data tailored to specific country editions
















